Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma

Reproductive Sciences

Volumn 22, Issue 11, 2015, Pages 1429-1435

  Zhou, Yi ^a   Zhu, Zhongyi ^b   Gao, Ya ^b   Yuan, Yuying ^b   Guo, Yulai ^b   Zhou, Lijun ^b   Liao, Kaikai ^b   Wang, Jun ^b   Du, Bole ^b   Hou, Yumei ^b   Chen, Zhonglin ^b   Chen, Fang ^c   Zhang, Hongyun ^b   Yu, Cong ^b   Zhao, Lijian ^b   Lau, T K ^d   Jiang, Fuman ^b   Wang, Wei ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Clinical Laboratory of BGI Health   (China)

^c BGI SHENZHEN   (China)

^d 4 F Central Building   (Hong Kong)

Author keywords

body mass index; fetal fraction; gestational age; multiples of the median.; preexisting hypertension; twin pregnancy

Indexed keywords

CELL FREE FETAL DNA; DNA; HEPATITIS B SURFACE ANTIGEN; UNCLASSIFIED DRUG; GENETIC MARKER;

ACCURACY; ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FETUS; FETUS DISEASE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL HYPERTENSION; MATERNAL PLASMA; MATERNAL WEIGHT; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; TRISOMY 18; TRISOMY 21; TWIN PREGNANCY; BLOOD; GENETIC MARKER; GENETIC SCREENING; GENETICS; HYPERTENSION; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PROCEDURES; RETROSPECTIVE STUDY; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ANEUPLOIDY; BODY MASS INDEX; DNA; FEMALE; FETUS; GENETIC MARKERS; GENETIC TESTING; GESTATIONAL AGE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY, TWIN; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84943800213     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719115584445     Document Type: Article

References (36)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350 (9076): 485-487.
2. Sikora A, Zimmermann BG, Rusterholz C, et al. Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem. 2010; 56 (1): 136-138.
3. Wang E, Batey A, Struble C, Musci T, Song K, Oliphant A,. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. 2013; 33 (7): 662-666.
4. Wataganara T, Peter I, Messerlian GM, Borgatta L, Bianchi DW,. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol. 2004; 104 (3): 545-550.
5. Alberry MS, Maddocks DG, Hadi MA, et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol. 2009; 200 (1): 98.e1-98.e6.
6. Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol. 2004; 190 (3): 707-713.
7. Al Nakib M, Desbrière R, Bonello N, et al. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther. 2009; 26 (1): 24-28.
8. Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH,. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks gestation: effect of maternal and fetal factors. Fetal Diagn Ther. 2012; 31 (4): 237-243.
9. Lapaire O, Volgmann T, Huang D, Hahn S, Holzgreve W, Zhong XY,. Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester. Obstet Gynecol. 2007; 110 (6): 1358-1363.
10. Pan PD, Peter I, Lambert-Messerlian GM, Canick JA, Bianchi DW, Johnson KL,. Cell-free fetal DNA levels in pregnancies conceived by IVF. Hum Reprod. 2005; 20 (11): 3152-3156.
11. Lee T, LeShane ES, Messerlian GM, et al. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol. 2002; 187 (5): 1217-1221.
12. Farina A, LeShane ES, Lambert-Messerlian GM, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem. 2003; 49 (2): 239-242.
13. Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC,. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn. 2007; 27 (2): 104-110.
14. Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW,. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem. 2014; 60 (1): 243-250.
15. Pergament E, Cuckle H, Zimmermann B, et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol. 2014; 124 (2 pt 1): 210-218.
16. Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014; 211 (5): 527.e1-527.e17.
17. Jiang F, Ren J, Chen F, et al. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics. 2012; 5: 57.
18. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn. 2012; 32 (13): 1225-1232.
19. Bianchi DW,. Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta., 2004; 25 (suppl A): S93-S101.
20. Benn P, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2013; 33 (7): 622-629.
21. Wataganara T, LeShane ES, Farina A, et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet. 2003; 112 (2): 204-208.
22. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH,. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2013; 41 (1): 26-32.
23. Baty BJ, Blackburn BL, Carey JC,. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet. 1994; 49 (2): 175-188.
24. Hahn S, Rusterholz C, Hösli I, Lapaire O,. Cell-free nucleic acids as potential markers for preeclampsia. Placenta. 2011; 32 (suppl): S17-S20.
25. Knight M, Redman CW, Linton EA, Sargent IL,. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998; 105 (6): 632-640.
26. Slonim DK, Koide K, Johnson KL, et al. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci USA. 2009; 106 (23): 9425-9429.
27. Muchova J, Zitnanova I, Durackova Z,. Oxidative stress and Down syndrome. Do antioxidants play a role in therapy? Physiol Res. 2014; 63 (5): 535-542.
28. Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014; 211 (4): 365.e1-365.e12.
29. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol, 2012; 207 (2): 137.e1-137.e8.
30. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH,. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012; 206 (4): 322.e1-322.e5.
31. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012; 119 (5): 890-901.
32. Lenfant C, Chobanian AV, Jones DW, Roccella EJ, Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension. 2003; 41 (6): 1178-1179.
33. Salmani D, Purushothaman S, Somashekara SC, et al. Study of structural changes in placenta in pregnancy-induced hypertension. J Nat Sci Biol Med. 2014; 5 (2): 352-355.
34. Bzowej NH,. Hepatitis B therapy in pregnancy. Curr Hepat Rep. 2010; 9 (4): 197-204.
35. Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 1991; 73 (2): 421-427.
36. Kelly L, Evans L, Messenger D,. Controversies around gestational diabetes. Practical information for family doctors. Can Fam Phys. 2005; 51: 688-695.